Related Experiment Video

Updated: Apr 12, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.6K

Biomarkers in Parkinson disease: It's time to combine

Martin J McKeown1, Guerry M Peavy2

  • 1From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego. martin.mckeown@ubc.ca.

Neurology
|May 17, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.1K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.2K

Related Experiment Videos

Last Updated: Apr 12, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.6K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.1K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.2K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation01:37

Neural Regulation

45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K

Articles linked to this work by shared authors, journal, and citation graph.

Impact of Video Quality on Video-Based Digital Assessment of Parkinson's Disease.

Digital biomarkers·2026

Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorder.

NPJ Parkinson's disease·2026

Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research.

Alzheimer's & dementia (New York, N. Y.)·2026

A Novel Eigen-Volume-based Co-Activation Pattern Framework for Dynamic Functional Biomarkers of Multiple Sclerosis.

IEEE journal of biomedical and health informatics·2026

Rapid Profiling of EEG Responses to Non-Invasive Brain Stimulation in Parkinson's Disease: A Biomarker-Driven Screening Framework.

Biomedicines·2026

A cognitive screening program in community-based medical clinics to facilitate Latino participation in Alzheimer's disease research.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Repairing the Amyotrophic Lateral Sclerosis Trial Credibility Gap.

Neurology·2026

Association Between Immigration Status and the Intensity of Acute Stroke Care in Ontario, Canada: A Retrospective Study.

Neurology·2026

Gestational Changes in Antiseizure Medication Concentrations and the Impact of Polytherapy: A Prospective Multicenter Cohort Study in China.

Neurology·2026

Prevalence of Slowly Expanding Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Neurology·2026

Pearls & Oy-sters: DPPX Antibody-Associated Encephalitis in a Patient With Diarrhea, Tremor, Ocular Flutter, and Cognitive-Psychiatric Changes.

Neurology·2026

Clinical Reasoning: A Patient With Progressive Sensory Neuropathy: Using Nerve Ultrasound and Skin Biopsy to Refine Diagnostic Reasoning.

Neurology·2026

Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.

BMJ medicine·2026

Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.

Frontiers in endocrinology·2026

The value of adrenal venous sampling in unveiling the conundrum of double unilateral adrenal adenomas in a case of primary hyperaldosteronism.

SAGE open medical case reports·2026

Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation.

Frontiers in pharmacology·2026

The Effect of a Global Health Shock on Preventive Drug Intake: Evidence from SHARE 2020-2022 for 15 European Countries.

Research square·2026

Pharmacotherapy of heart failure: Impact of the 2021 guideline update on guideline-directed medical therapy assessed using a Japanese employee health insurance claims database.

International journal of clinical pharmacology and therapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us